416 related articles for article (PubMed ID: 16822601)
21. Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder.
Maron E; Tõru I; Must A; Tasa G; Toover E; Vasar V; Lang A; Shlik J
Neurosci Lett; 2007 Jan; 411(3):180-4. PubMed ID: 17123728
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of mindfulness-based cognitive therapy as an adjuvant to pharmacotherapy in patients with panic disorder or generalized anxiety disorder.
Kim YW; Lee SH; Choi TK; Suh SY; Kim B; Kim CM; Cho SJ; Kim MJ; Yook K; Ryu M; Song SK; Yook KH
Depress Anxiety; 2009; 26(7):601-6. PubMed ID: 19242985
[TBL] [Abstract][Full Text] [Related]
23. Serotonin transporter, tryptophan hydroxylase, and monoamine oxidase A gene polymorphisms in premenstrual dysphoric disorder.
Magnay JL; Ismail KM; Chapman G; Cioni L; Jones PW; O'Brien S
Am J Obstet Gynecol; 2006 Nov; 195(5):1254-9. PubMed ID: 17026953
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the serotonin transporter promoter rs25531 polymorphism in premenstrual dysphoric disorder.
Magnay JL; El-Shourbagy M; Fryer AA; O'Brien S; Ismail KM
Am J Obstet Gynecol; 2010 Aug; 203(2):181.e1-5. PubMed ID: 20462563
[TBL] [Abstract][Full Text] [Related]
25. [Association of serotonin and norepinephrine transporter gene polymorphisms with the susceptibility to depression].
Min WJ; Ma XH; Li T; Zhang B; Sun XL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):388-92. PubMed ID: 20017301
[TBL] [Abstract][Full Text] [Related]
26. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
[TBL] [Abstract][Full Text] [Related]
27. Interaction between the tryptophan hydroxylase gene and the serotonin transporter gene in schizophrenia but not in bipolar or unipolar affective disorders.
Chotai J; Serretti A; Lorenzi C
Neuropsychobiology; 2005; 51(1):3-9. PubMed ID: 15627807
[TBL] [Abstract][Full Text] [Related]
28. Genetic moderation of CO2-induced fear by 5-HTTLPR genotype.
Schruers K; Esquivel G; van Duinen M; Wichers M; Kenis G; Colasanti A; Knuts I; Goossens L; Jacobs N; van Rozendaal J; Smeets H; van Os J; Griez E
J Psychopharmacol; 2011 Jan; 25(1):37-42. PubMed ID: 20584994
[TBL] [Abstract][Full Text] [Related]
29. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
30. Serotonin transporter gene promoter polymorphism and somatoform symptoms.
Hennings A; Zill P; Rief W
J Clin Psychiatry; 2009 Nov; 70(11):1536-9. PubMed ID: 19538902
[TBL] [Abstract][Full Text] [Related]
31. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
Kang RH; Wong ML; Choi MJ; Paik JW; Lee MS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1317-21. PubMed ID: 17618721
[TBL] [Abstract][Full Text] [Related]
32. Psychological vulnerability differences in students--carriers or not of the serotonin transporter promoter allele S: effect of adverse experiences.
Veletza S; Samakouri M; Emmanouil G; Trypsianis G; Kourmouli N; Livaditis M
Synapse; 2009 Mar; 63(3):193-200. PubMed ID: 19086091
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of a mindfulness-based cognitive therapy program as an adjunct to pharmacotherapy in patients with panic disorder.
Kim B; Lee SH; Kim YW; Choi TK; Yook K; Suh SY; Cho SJ; Yook KH
J Anxiety Disord; 2010 Aug; 24(6):590-5. PubMed ID: 20427148
[TBL] [Abstract][Full Text] [Related]
34. The tryptophan hydroxylase (TPH) 2 gene unlike TPH-1 exhibits no association with stress-induced depression.
Gizatullin R; Zaboli G; Jönsson EG; Asberg M; Leopardi R
J Affect Disord; 2008 Apr; 107(1-3):175-9. PubMed ID: 17692928
[TBL] [Abstract][Full Text] [Related]
35. The A218C polymorphism of tryptophan hydroxylase gene and migraine.
Erdal N; Herken H; Yilmaz M; Erdal E; Bayazit YA
J Clin Neurosci; 2007 Mar; 14(3):249-51. PubMed ID: 17194593
[TBL] [Abstract][Full Text] [Related]
36. TPH2 -703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression.
Yoon HK; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):403-9. PubMed ID: 19162119
[TBL] [Abstract][Full Text] [Related]
37. No association between the TPH A218C polymorphism and personality traits in Japanese healthy subjects.
Suzuki A; Fukasawa T; Shiraishi H; Ishii G; Oshino S; Aoshima T; Otani K
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):395-8. PubMed ID: 17116352
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of obsessive-compulsive-, panic-, obsessive-compulsive personality-, and non-disordered individuals by variation in the promoter region of the serotonin transporter gene.
Perez M; Brown JS; Vrshek-Schallhorn S; Johnson F; Joiner TE
J Anxiety Disord; 2006; 20(6):794-806. PubMed ID: 16303282
[TBL] [Abstract][Full Text] [Related]
39. Family based association analyses between the serotonin transporter gene polymorphism (5-HTTLPR) and neuroticism, anxiety and depression.
Middeldorp CM; de Geus EJ; Beem AL; Lakenberg N; Hottenga JJ; Slagboom PE; Boomsma DI
Behav Genet; 2007 Mar; 37(2):294-301. PubMed ID: 17216342
[TBL] [Abstract][Full Text] [Related]
40. No association between the -399 C > T polymorphism of the neuropeptide Y gene and schizophrenia, unipolar depression or panic disorder in a Danish population.
Lindberg C; Koefoed P; Hansen ES; Bolwig TG; Rehfeld JF; Mellerup E; Jørgensen OS; Kessing LV; Werge T; Haugbøl S; Wang AG; Woldbye DP
Acta Psychiatr Scand; 2006 Jan; 113(1):54-8. PubMed ID: 16390370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
